Surgery for Thumb Base Osteoarthritis: Joint Replacement vs. Trapeziectomy (BASTION)
BASTION - BASe of Thumb Osteoarthritis Management Non-inferiority Trial: Surgical Treatment of First Carpometacarpal Joint Osteoarthritis: A Comparison Between Joint Replacement and Trapeziectomy
The goal of this clinical trial is to learn if the surgical method with total joint arthroplasty, (TOUCH joint prosthesis), is as good as or better than the traditional surgical method, trapezectomy, to treat thumb base joint osteoarthritis.
The main questions it aims to answer are:
Does surgery with total joint arthroplasty provide better power grip and pinch grip strength compared to traditional surgery?
What is the long-term risk of complications for both methods?
Which method is more cost-effective for the healthcare system?
Researchers will compare total joint arthroplasty (TOUCH) to trapezectomy (a procedure where a bone in the thumb base is removed) to see which method provides the best results for the patient.
Participants will:
Be randomized to undergo either an operation with total joint arthroplasty or a trapezectomy.
Undergo an initial evaluation and a health economic cost analysis after one year.
Attend follow-up checkups at 2, 5, and 10 years post-surgery to evaluate long-term function and the durability of the prosthesis.
研究概览
地位
详细说明
Background and Rationale:
Basal joint arthritis of the thumb (trapeziometacarpal osteoarthritis) is a common condition causing pain and reduced hand function. While trapeziectomy with ligament reconstruction/capsuloplasty has long been a gold standard, total joint arthroplasty, such as the TOUCH prosthesis, has gained popularity. However, there is a lack of high-quality prospective randomized controlled trials (RCTs) comparing these methods regarding long-term functional outcomes, complication rates, and cost-effectiveness. This study aims to compare the clinical and health-economic outcomes of total joint arthroplasty with TOUCH prosthesis versus trapeziectomy with capsuloplasty.
Study Design and Randomization:
This is a prospective, randomized controlled trial. Following informed consent obtained by the attending surgeon, participants are randomized to either:
- Total joint arthroplasty using the TOUCH prosthesis.
- Trapeziectomy with capsuloplasty. Randomization is performed in close proximity to the day of surgery. Due to the nature of the interventions, participants are informed of the surgical method postoperatively.
Procedures and Follow-up
- Surgical Intervention: Both procedures are performed according to standardized institutional protocols.
- Postoperative Care (Trapeziectomy): The thumb is immobilized in a cast for 3 weeks, followed by a standardized rehabilitation program led by occupational and physical therapists.
- Postoperative Care (total joint arthroplasty): A stable soft dressing is applied for 3 weeks, followed by the same rehabilitation protocol.
- Follow-up Schedule: Participants are evaluated at 3 weeks, 6 weeks, 12 weeks, 12 months, 24 months, 5 years, and 10 years postoperatively.
- Imaging: Radiographic evaluations are performed for the prosthesis group at 6 weeks, 12 months, 24 months, 5 years, and 10 years to monitor for prosthesis loosening or "z-deformity" (MCP joint hyperextension) compared to the trapeziectomy group.
Data Management and Quality Assurance:
Data is collected and managed using REDCap (Research Electronic Data Capture) to ensure data integrity and validation. Physical informed consent forms are stored securely at the Department of Hand Surgery. Source data verification is performed by comparing registry data against electronic medical records and paper-based Case Report Forms (CRFs).
Sample Size and Power Calculation:
The primary outcome is Jamar grip strength at 12 months. Based on a Minimal Clinically Important Difference (MCID) of 6.5 kg and a standard deviation (SD) of 8.5 kg (derived from existing literature and pilot data), a power calculation (90% power, alpha 0.05, two-sided t-test) determined a requirement of 37 patients per group. To account for a 10% dropout rate, the total cohort size is set at 84 patients (42 per arm).
Health Economic Analysis:
A comprehensive health economic evaluation will be conducted to compare the total costs of both methods. This analysis includes:
- Direct Costs: Implant costs, anesthesia, surgical time, and healthcare utilization (number of visits).
- Indirect Costs: Duration of sick leave and time to return to work.
- Secondary Metrics: Analgesic consumption (paracetamol and opioids), patient-reported quality of life (EQ-5D), and "pain-free days" based on NRS (Numerical Rating Scale) assessments.
The objective is to determine if the higher initial cost of the TOUCH prosthesis is offset by faster recovery, reduced sick leave, and improved long-term productivity.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Eva Nordin, Clinical research nurse
- 电话号码:+46(0) 186119630
- 邮箱:eva.nordin@akademiska.se
研究联系人备份
- 姓名:Elias Gardell, MD, attending hand surgeon
- 电话号码:+46 (0) 186171544
- 邮箱:elias.gardell@uu.se
学习地点
-
-
-
Uppsala、瑞典
- 招聘中
- Department of Handsurgery, Uppsala University Hospital
-
接触:
- Elias Gardell, MD, attending hand surgeon
- 电话号码:+46(0) 186171544
- 邮箱:elias.gardell@uu.se
-
接触:
- Sara Edsfeldt, MD, PhD, senior attending
- 电话号码:+46 (0) 186119031
- 邮箱:sara.edsfeldt@uu.se
-
首席研究员:
- Sara Edsfeldt, MD, PhD, senior attending
-
Örebro、瑞典
- 尚未招聘
- Örebro University Hospital
-
接触:
- Eva Lundqvist, MD, PhD, senior attending
- 电话号码:+46(0) 196025175
- 邮箱:eva.lundqvist@regionorebrolan.se
-
首席研究员:
- Eva Lundqvist, MD, PhD, senior attending
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age 40-80 years at inclusion
- CMC-joint osteoarthritis grade 1-3 (Eaton-Littler classification)
- Rest pain or pain reducing hand function with indication for surgery
- Insufficient relief from non-operative treatment for ≥3 months (orthosis, OTC analgesics, cortisone injection)
- Eligible for both prosthesis and trapezectomy per including surgeon
- Non-smoker or complete smoking cessation ≥6 weeks prior to surgery
Exclusion Criteria:
- Previous surgery to thumb base or STT-joint
- Ongoing chronic pain condition
- Dementia or cognitive impairment
- Trapezium height <7 mm on plain radiograph
- Active smoker
- Osteoarthritis grade 4 (Eaton-Littler)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Arm 1 -Dual Mobility Prosthesis (TOUCH)
TOUCH Total Joint Arthroplasty (n=42).
Implantation of TOUCH trapeziometacarpal prosthesis (Kerimedical).
Soft bandage for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
|
Surgical implantation of the TOUCH trapeziometacarpal total joint prosthesis (Kerimedical).
The prosthesis consists of an uncemented stainless steel stem inserted into the first metacarpal and a dual cup mobility system with a polyethylene ball articulating against a metal cup fixed in the trapezium.
The stem is available in straight or 15-degree angled neck configurations.
Postoperative management consists of a stable soft dressing for 3 weeks to allow early controlled mobilization, followed by a standardized hand therapy rehabilitation protocol.
其他名称:
|
|
有源比较器:Arm 2 - Trapeziectomy and Capsular Reconstruction
Trapezectomy with capsuloplasty (n=42).
Excision of trapezium with dorsal capsule flap capsuloplasty.
Cast immobilization for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
|
Surgical excision of the trapezium bone (trapeziectomy) followed by capsuloplasty using a distally based dorsal capsular flap, without tendon interposition.
The capsular flap is sutured to stabilize the base of the first metacarpal.
No implant or tendon graft is used.
Postoperatively, a cast immobilizing the thumb in functional position is applied for 3 weeks, followed by a standardized hand therapy rehabilitation protocol.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Hand grip strength
大体时间:Measured at 12 months postoperatively
|
Hand grip strength (JAMAR dynamometer) at 12 months post operatively
|
Measured at 12 months postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Key-pinch grip strength
大体时间:Measured at 6 weeks, 12 weeks, and 12 months postoperatively
|
Key-pinch strength measured by pinch-gauge in kilograms
|
Measured at 6 weeks, 12 weeks, and 12 months postoperatively
|
|
Pinch grip strength
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
3-finger pinch strength measured by pinch gauge in kilograms
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Postoperative Pain Intensity on a Numeric Rating Scale (NRS)
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Pain measured with the Numerical Rating Scale (NRS) at rest and load, where 0 is "no pain" and 10 is "worst imaginable pain"
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Range of movement
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Range of movement of thumb measured by physiotherapist.
Extension, flexion, volar abduction, radial abduction.
In degrees.
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Metacarpophalangeal (MCP)-joint hyperextension
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Radiographic MCP-joint hyperextension (Z-deformity)
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Complications
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Complications, such as trigger thumb, de Quervain's, reoperation, and infection, reported within 12 months of surgery.
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Use of analgesics
大体时间:Measured at 12 months postoperatively
|
Total usage of analgesic during the post operative period.
|
Measured at 12 months postoperatively
|
|
Duration of sick leave
大体时间:Measured at 12 months postoperatively
|
Total duration of sick leave.
|
Measured at 12 months postoperatively
|
|
Patient-reported outcomes EQ-5D
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Patient-reported outcome of the hand surgery using validated questionnaire EQ-5D
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Patient-reported outcomes PRWHE
大体时间:Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Patient-reported outcome of the hand surgery using validated questionnaire PRWHE
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
合作者和调查者
调查人员
- 研究主任:Nils Hailer, MD, PhD. Professor、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
- 首席研究员:Sara Edsfeldt, MD, PhD, senior attending、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
- 学习椅:Sara Edsfeldt, MD, PhD, senior attending、Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
出版物和有用的链接
一般刊物
- Kim JK, Park MG, Shin SJ. What is the minimum clinically important difference in grip strength? Clin Orthop Relat Res. 2014 Aug;472(8):2536-41. doi: 10.1007/s11999-014-3666-y. Epub 2014 May 10.
- Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil. 2008 Sep;89(9):1693-700. doi: 10.1016/j.apmr.2008.02.022.
- Kriegs-Au G, Petje G, Fojtl E, Ganger R, Zachs I. Ligament reconstruction with or without tendon interposition to treat primary thumb carpometacarpal osteoarthritis. A prospective randomized study. J Bone Joint Surg Am. 2004 Feb;86(2):209-18. doi: 10.2106/00004623-200402000-00001.
- Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019 Jan;31(1):75-78. doi: 10.1589/jpts.31.75. Epub 2019 Jan 10.
- Werle S, Goldhahn J, Drerup S, Simmen BR, Sprott H, Herren DB. Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population. J Hand Surg Eur Vol. 2009 Feb;34(1):76-84. doi: 10.1177/1753193408096763. Epub 2009 Jan 7.
- Herren DB, Marks M, Neumeister S, Schindele S. Low complication rate and high implant survival at 2 years after Touch(R) trapeziometacarpal joint arthroplasty. J Hand Surg Eur Vol. 2023 Oct;48(9):877-883. doi: 10.1177/17531934231179581. Epub 2023 Jun 13.
- Kierkegaard M, Petitclerc E, Hebert LJ, Mathieu J, Gagnon C. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. J Rehabil Med. 2018 Feb 28;50(3):269-277. doi: 10.2340/16501977-2304.
- Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Leger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group. Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar. J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.
- Guzzini M, Arioli L, Annibaldi A, Pecchia S, Latini F, Ferretti A. Interposition Arthroplasty versus Dual Cup Mobility Prosthesis in Treatment of Trapeziometacarpal Joint Osteoarthritis: A Prospective Randomized Study. Hand (N Y). 2024 Nov;19(8):1260-1268. doi: 10.1177/15589447231185584. Epub 2023 Jul 23.
- Newton A, Talwalkar S. Arthroplasty in thumb trapeziometacarpal (CMC joint) osteoarthritis: An alternative to excision arthroplasty. J Orthop. 2022 Nov 26;35:134-139. doi: 10.1016/j.jor.2022.11.011. eCollection 2023 Jan.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
- 成本效益分析
- 前瞻性研究
- 握力
- 假肢
- 第一腕掌关节
- 比较研究
- 随机对照试验 (RCT)
- 根瘤病
- 梯形切除术
- 重返工作岗位
- 手外科
- 拇指骨关节炎
- 前瞻性研究
- EQ-5D
- 全关节置换术
- 生活质量 (QoL)
- 患者报告的结果测量 (PROM)
- 卫生经济学
- 快速破折号
- 健康相关生活质量 (HRQoL)
- 捏力
- 成本效益分析
- 手术重建
- 腕掌关节
- Thumb base arthroplasty
- CMC joint
- Dual Mobility Prosthesis
- Total Joint Replacement
- Ligament Reconstruction
- Michigan Hand Outcomes Questionnaire (MHQ
其他相关的 MeSH 术语
其他研究编号
- Dnr2026-00547-01
- 2026-00547-01 (其他标识符:Swedish Ethical Review Authority)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.